Pressroom: Media Coverage

Showing 441 - 460 of 656 news items


Cancer Survivors Face a New Challenge in Care

Survivorship Initiative Director Mary McCabe commented on the importance of cancer survivorship programs. She said these programs ensure that cancer survivors receive proper follow-up care and teach survivors how to communicate their needs to their healthcare team.

May 17, 2012
Aveo Kidney Cancer Drug More Tolerated Than Nexavar

Medical oncologist Robert Motzer discussed encouraging findings from a phase III study he led comparing the safety and efficacy of two kidney cancer drugs. Dr. Motzer’s team found that patients taking the investigational drug tivozanib were half as likely to need a break from the medication due to side effects as patients taking sorafenib (Nexavar®).

May 16, 2012
Complex Immune-Based Cancer Treatment Shows Signs of Progress

Michel Sadelain, Center for Cell Engineering Director, discussed the burgeoning field of adoptive cell transfer (ACT) as a treatment for cancer. Dr. Sadelain, who is involved in several ACT trials at Memorial Sloan Kettering, notes that interest in these types of cell-based therapies is growing, but serious hurdles must be overcome if any form of ACT is to become widely available.

May 15, 2012
With Biotechs Back in Limelight, OPKO's Alzheimer's Diagnostic and Other Products Catch Investors' Eye

Surgery Department Chair Peter Scardino spoke about biomarkers developed at Memorial Sloan Kettering that, when used together with PSA tests, can reduce the need for prostate biopsies by more than 50 percent.

May 13, 2012
Finding a Match, and a Mission: Helping Blacks Survive Cancer

Memorial Sloan Kettering patient Seun Adebiyi launched Nigeria’s national bone marrow registry after experiencing firsthand the difficulty of finding donors for patients of African descent.

May 12, 2012
Sunscreen Fears

Dermatologist Kishwer Nehal was interviewed about research from Missouri University of Science and Technology that looked at what happens to cells containing zinc oxide when exposed to sunlight.

May 11, 2012
Risky Surgical Business

Gynecologic oncologist Douglas Levine spoke about risk-reducing surgery for carriers of BRCA gene mutations. BRCA gene mutations, which are much more prevalent in Jewish people of Ashkenazi descent than in the general population, increase the likelihood of developing ovarian or breast cancer.

May 8, 2012
Training Immune System to Fight Cancer Comes of Age

Medical oncologist Jedd Wolchok was interviewed about immunotherapy – the harnessing of the body’s immune system to fight cancer – and how it has turned certain cancers into chronic diseases for patients rather than fatal ones.

May 7, 2012
Gene Therapy Safe in Decade-Long HIV Study That May Widen Use

Michel Sadelain, Center for Cell Engineering Director, discussed encouraging findings of a recent study that found that HIV patients given gene therapy more than a decade ago are healthy and the altered DNA they received remains stable in their bodies. The study suggests that this treatment may safely be tested as a way to attack other illnesses.

May 2, 2012
Studies Reignite Mammography Debate For Middle-Aged Women

Diagnostic radiologist Carol Lee spoke about mammography for women in their 40s. Recent studies suggest that women with a low risk of breast cancer do not need regular mammograms until age 50, but Dr. Lee warns that the studies “may discourage women who don’t have an identifiable risk factor from seeking screening, and therefore the potential lifesaving benefit of screening won’t be realized.”

April 30, 2012
Do We "Waste" Money on Terminal Patients? (Part II)

Director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes Peter Bach continued his discussion with American historian and broadcaster Richard Heffner about the cost of medical care.

April 28, 2012
What You Don't Know About Cancer

Human Oncology and Pathogenesis Program Chair Charles Sawyers spoke about the excitement around the emerging role of DNA in the fight against cancer. He said, “There has never been a time of greater optimism about the future of cancer therapy.”

April 23, 2012
Strides are Being Made in the Treatment of Neuroblastoma

Pediatric oncologist Shakeel Modak spoke about new treatments for neuroblastoma that are being pioneered by oncologists at Memorial Sloan Kettering.

April 23, 2012
Skin Cancer Prevention Tips

Dermatology Service Chief Allan Halpern offered skin cancer prevention tips and discussed sun safety with Martha Stewart and Debra Black of the Melanoma Research Alliance.

April 23, 2012
Do We "Waste" Money on Terminal Patients?

Director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes Peter Bach discussed a recent essay he wrote in The New York Times about the amount of money spent on providing care to patients who may die.

April 21, 2012
Cancer Patients Suffer Unnecessary Pain

Pain and Palliative Care Service Chief Paul Glare commented on a study that found that as many as one-third of cancer patients may be receiving inadequate treatment to control their pain, even though many medicines are available to help.

April 19, 2012
Is Warren Buffett's Cancer Treatment Necessary?

Department of Surgery Chair Peter Scardino discussed prostate cancer diagnosis, screening, and treatment in light of Warren Buffet’s announcement that he will undergo radiation therapy for stage I prostate cancer.

April 18, 2012
How a Geiger Counter Helps Breast Cancer Patients

Breast Surgical Service Chief Monica Morrow was interviewed about the advantages of a new, more patient-friendly approach called radioactive seed localization, which is being used to locate and remove very small breast cancers that can only be seen by mammography.

April 18, 2012
The Push for Daily Sunscreen

Head of Memorial Sloan Kettering’s Basking Ridge Dermatology Section Steven Wang spoke about new FDA guidelines for sun-protection products, including cosmetics with sunscreen. The new guidelines state that products must pass a test to show they protect against both UVA and UVB rays and must clearly be labeled “broad spectrum” followed by an SPF number.

April 10, 2012
Can a Computer Diagnose, Treat Cancer?

Thoracic Oncology Service Chief Mark Kris spoke with CNN’s Erin Burnett about the collaboration between Memorial Sloan Kettering and IBM to develop a supercomputer to support oncologists based upon IBM’s Watson technology. He said, “The beautiful thing about Watson is that it extracts the information. It does not tell you an answer. It tells you the possible answers.”

April 9, 2012